Cartesian Therapeutics Inc
F:1S70
Cartesian Therapeutics Inc
F:1S70
Price:
6.5
EUR
11.11%
Market Closed
Market Cap:
€169m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cartesian Therapeutics Inc
F:1S70
|
US |
|
Z
|
Zillow Group Inc
F:0ZG
|
US |
|
V
|
Verona Pharma PLC
F:I9SA
|
UK |
|
P
|
PSI Software AG
XBER:PSAN
|
DE |
|
M
|
Moody's Corp
DUS:DUT
|
US |
|
Aedifica NV
F:AOO
|
BE |
|
Fox Corp
F:FO5
|
US |
|
T
|
Trane Technologies PLC
XMUN:2IS
|
IE |
|
C
|
Canadian Pacific Railway Ltd
F:PC8
|
CA |
|
Happinet Corp
OTC:HAPYF
|
JP |
|
E
|
Eva Precision Industrial Holdings Ltd
F:GZT
|
HK |
|
M
|
Microport Scientific Corp
OTC:MCRPF
|
CN |
|
Kernel Holding SA
F:0KE
|
UA |
|
B
|
Bio-Techne Corp
SWB:TE1
|
US |
|
UL Solutions Inc
F:72R
|
US |
|
S
|
Safran SA
XMUN:SEJ1
|
FR |
|
S
|
Schlumberger NV
SWB:SCL
|
US |
|
M
|
Mckesson Corp
XBER:MCK
|
US |
Wall St Price Targets
1S70 Price Targets Summary
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc
Wall Street analysts forecast 1S70 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1S70 is 38.17 EUR with a low forecast of 17 EUR and a high forecast of 48.6 EUR.
Lowest Forecast
Price Target
17
EUR
162% Upside
Average Forecast
Price Target
38.17
EUR
487% Upside
Highest Forecast
Price Target
48.6
EUR
648% Upside
Cartesian Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S70's stock price target?
Price Target
38.17
EUR
38.17
EUR
According to Wall Street analysts, the average 1-year price target for 1S70 is 38.17 EUR with a low forecast of 17 EUR and a high forecast of 48.6 EUR.
What is the Revenue forecast for Cartesian Therapeutics Inc?
Projected CAGR
105%
105%
Over the last 10 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 8 years is 105%.
